|
US6121036A
(en)
*
|
1996-04-15 |
2000-09-19 |
Ghanbari; Hossein A. |
Compositions containing bacteriophages and methods of using bacteriophages to treat infections
|
|
GB9809414D0
(en)
*
|
1998-05-02 |
1998-07-01 |
Scottish Crop Research Inst |
Method
|
|
GB9908195D0
(en)
|
1999-04-09 |
1999-06-02 |
Microbiological Res Authority |
Treatment of intracellular infection
|
|
US6440405B1
(en)
*
|
1999-06-07 |
2002-08-27 |
University Of Delaware |
Quaternary ammonium functionalized dendrimers and methods of use therefor
|
|
AU2001230889A1
(en)
*
|
2000-01-11 |
2001-07-24 |
Intralytix, Inc. |
Method and device for sanitation using bacteriophages
|
|
US20040191224A1
(en)
*
|
2000-01-11 |
2004-09-30 |
Intralytix, Inc. |
Method and device for sanitation using bacteriophages
|
|
US6485902B2
(en)
|
2000-06-06 |
2002-11-26 |
Thomas E. Waddell |
Use of bacteriophages for control of escherichia coli O157
|
|
DE10042853A1
(de)
*
|
2000-08-30 |
2002-04-25 |
Florian Lang |
Nachweis und Beeinflußung der Expression oder Funktion von CD95/CD95L bei Infektionen
|
|
WO2002034892A1
(en)
*
|
2000-10-25 |
2002-05-02 |
Intercell Biomedizinische Forschungs- Und Entwicklungs Ag |
Modified phage, comprising a non-lytic modification and expressing a kil-gene
|
|
MXPA03004182A
(es)
*
|
2000-11-13 |
2004-03-26 |
Univ Iowa State Res Found Inc |
Composiciones y metodos para reducir la cantidad de salmonella en el ganado.
|
|
US6461608B1
(en)
*
|
2000-11-22 |
2002-10-08 |
Nymox Pharmaceutical Corporation |
Bacteriophage composition useful in treating food products to prevent bacterial contamination
|
|
DE10115310A1
(de)
*
|
2001-03-28 |
2002-10-10 |
Nodar A Daniela |
Bakteriophagen-Präparation
|
|
CA2444819A1
(en)
*
|
2001-04-19 |
2002-10-31 |
Biophage, Inc. |
Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages
|
|
EP1406642B1
(en)
*
|
2001-07-18 |
2007-02-28 |
Instytut Immunologii I Terapii Doswiadczalnej-Pan |
Methods of polyvalent bacteriophage preparation for the treatment of bacterial infections
|
|
PL354822A1
(en)
*
|
2002-06-30 |
2004-01-12 |
Instytut Immunologii i Terapii Doświadczalnej PANwe Wrocławiu |
Method of receiving purified bacteriophage preparations and new applications of polysaccharide or its esterificated derivative
|
|
AU2002366854A1
(en)
*
|
2001-12-13 |
2003-07-09 |
Societe Des Produits Nestle S.A. |
Isolated phages and their use in food or pet food products
|
|
US6759229B2
(en)
*
|
2001-12-18 |
2004-07-06 |
President & Fellows Of Harvard College |
Toxin-phage bacteriocide antibiotic and uses thereof
|
|
US7514407B2
(en)
*
|
2002-03-04 |
2009-04-07 |
Nymox Corporation |
Spheron component peptides and pharmaceutical compositions
|
|
NZ535275A
(en)
*
|
2002-03-04 |
2007-03-30 |
Nymox Corp |
Spheron components useful in determining compounds capable of treating symptoms of alzheimer's disease, and treatments and animal models produced therefrom
|
|
GB0207021D0
(en)
*
|
2002-03-25 |
2002-05-08 |
Univ Warwick |
Anti-bacterial agents
|
|
DE60315636T2
(de)
*
|
2002-03-25 |
2008-05-08 |
University Of Warwick, Coventry |
Zur therapie und prophylaxe bakterieller infektionen geeignete bakteriophagen
|
|
AU2003240505A1
(en)
*
|
2002-06-05 |
2003-12-22 |
Iowa State University Research Foundation, Inc. |
Bacteriophage and enzymes lytic to salmonellae
|
|
RU2232808C1
(ru)
*
|
2002-10-11 |
2004-07-20 |
Закрытое акционерное общество "ПИ - ПРО - ЛАЙФ" |
Биопрепарат на основе бактериофагов для профилактики и лечения сальмонеллеза животных
|
|
RU2244747C2
(ru)
*
|
2002-11-01 |
2005-01-20 |
Закрытое акционерное общество "ПИ-ПРО-ЛАЙФ" |
Биопрепарат на основе бактериофагов для профилактики и лечения колибактериоза (эшерихиоза) животных
|
|
WO2004046319A2
(en)
*
|
2002-11-14 |
2004-06-03 |
Gangagen, Inc. |
Bacteriophage having modified holin and uses thereof
|
|
GB0300597D0
(en)
*
|
2003-01-10 |
2003-02-12 |
Microbiological Res Authority |
Phage biofilms
|
|
US7807149B2
(en)
*
|
2003-07-23 |
2010-10-05 |
Biocontrol Limited |
Bacteriophage-containing therapeutic agents
|
|
CA2541941C
(en)
*
|
2003-10-06 |
2015-05-26 |
Gangagen, Inc. |
Anti-bacterial phage tail compositions and uses thereof
|
|
US20060153811A1
(en)
*
|
2005-01-10 |
2006-07-13 |
Jackson Lee E |
Use of viruses and virus-resistant microorganisms for controlling microorganism populations
|
|
AU2006268420B2
(en)
*
|
2005-07-12 |
2012-06-28 |
Micreos B.V. |
Bacteriophage and their uses
|
|
JP2007084492A
(ja)
*
|
2005-09-22 |
2007-04-05 |
Hiroshima Univ |
バクテリオファージを含む、細菌性感染症治療用の薬剤
|
|
US20090053179A1
(en)
*
|
2005-10-05 |
2009-02-26 |
Internalle, Inc. |
Method for using liberated dormant bacteriophage and environmental stress to reduce infectious bacteria
|
|
US20070173787A1
(en)
*
|
2005-11-01 |
2007-07-26 |
Huang Mark C T |
Thin-film nitinol based drug eluting stent
|
|
EP2004800B1
(en)
|
2006-04-04 |
2014-01-15 |
Henry Morris Krisch |
Process of production of bacteriophage compositions and methods in phage therapy field
|
|
US20070292397A1
(en)
*
|
2006-06-19 |
2007-12-20 |
Mcnulty Amy K |
Method for the detection and neutralization of bacteria
|
|
KR100781669B1
(ko)
*
|
2006-06-20 |
2007-12-03 |
주식회사 인트론바이오테크놀로지 |
황색포도상구균 특이적 사멸능을 갖는 박테리오파지
|
|
KR100759988B1
(ko)
*
|
2006-08-04 |
2007-09-19 |
주식회사 인트론바이오테크놀로지 |
황색포도상구균에 특이적인 항균 단백질
|
|
GB0704553D0
(en)
*
|
2007-03-09 |
2007-04-18 |
Harper David R |
Beneficial effects of bacteriophage treatments
|
|
KR100924661B1
(ko)
*
|
2007-08-16 |
2009-11-03 |
주식회사 인트론바이오테크놀로지 |
황색포도상구균 특이적 사멸능을 갖는 포도비리대박테리오파지
|
|
KR100910961B1
(ko)
|
2007-09-13 |
2009-08-05 |
주식회사 인트론바이오테크놀로지 |
황색포도상구균의 균막 처치에 효과적인 박테리오파지 또는그것 유래의 용균단백질
|
|
US8956628B2
(en)
*
|
2007-12-13 |
2015-02-17 |
Zoetis Products Llc |
Bacteriophage preparations and method of use thereof
|
|
RU2366456C1
(ru)
*
|
2007-12-17 |
2009-09-10 |
Николай Васильевич Пименов |
Препарат против сальмонеллеза голубей и способ лечения сальмонеллеза голубей
|
|
GB0800149D0
(en)
*
|
2008-01-04 |
2008-02-13 |
Novolytics Ltd |
Improved host range phage
|
|
RU2375075C1
(ru)
*
|
2008-04-24 |
2009-12-10 |
Государственное научное учреждение Всероссийский научно-исследовательский институт экспериментальной ветеринарии им. Я.Р. Коваленко РАСХН (ВИЭВ) |
Способ лечения птиц при сальмонеллезе, вызванном salmonella typhimurium
|
|
US7745194B2
(en)
*
|
2008-09-16 |
2010-06-29 |
Intralytix, Inc. |
Staphylococcus aureus: bacteriophage and uses thereof
|
|
KR101070938B1
(ko)
*
|
2008-12-02 |
2011-10-06 |
씨제이제일제당 (주) |
신규한 박테리오파지 및 이를 포함하는 항균 조성물
|
|
GB2466177A
(en)
*
|
2008-12-03 |
2010-06-16 |
Arab Science & Technology Found |
Bacteriophage selection and breeding
|
|
US8771936B2
(en)
|
2008-12-24 |
2014-07-08 |
Cj Cheiljedang Corporation |
Bacteriophage and antibacterial composition comprising the same
|
|
KR101151516B1
(ko)
*
|
2008-12-24 |
2012-05-30 |
씨제이제일제당 (주) |
신규한 박테리오파지 및 이를 포함하는 항균 조성물
|
|
JP5720045B2
(ja)
*
|
2008-12-26 |
2015-05-20 |
国立大学法人東京工業大学 |
スタフィロコッカス・アウレウス溶菌性バクテリオファージ
|
|
US8043613B2
(en)
*
|
2009-02-12 |
2011-10-25 |
Intron Biotechnology, Inc. |
Podoviriedae bacteriophage having killing activity specific to Staphylococcus aureus
|
|
US8377866B2
(en)
*
|
2009-02-12 |
2013-02-19 |
Intron Biotechnology, Inc. |
Antimicrobial protein derived from Podoviridae bacteriophage specific to Staphylococcus aureus
|
|
AU2010212270B2
(en)
|
2009-08-12 |
2015-02-19 |
Buddhist Tzu Chi Medical Foundation |
Disinfectant composition comprising phage
|
|
US20110052543A1
(en)
*
|
2009-09-03 |
2011-03-03 |
Cj Cheiljedang Corporation |
Novel bacteriophage and antibacterial composition comprising the same
|
|
US8846368B2
(en)
|
2009-09-03 |
2014-09-30 |
Cj Cheiljedang Corporation |
Bacteriophage and antibacterial composition comprising the same
|
|
WO2011028061A2
(en)
*
|
2009-09-03 |
2011-03-10 |
Cj Cheiljedang Corporation |
Novel bacteriophage and antibacterial composition comprising the same
|
|
EP2475377B1
(en)
*
|
2009-09-03 |
2016-01-06 |
CJ CheilJedang Corporation |
Novel bacteriophage and antibacterial composition comprising the same
|
|
WO2011028057A2
(en)
*
|
2009-09-03 |
2011-03-10 |
Cj Cheiljedang Corporation |
Novel bacteriophage and antibacterial composition comprising the same
|
|
KR101101377B1
(ko)
|
2009-10-16 |
2012-01-02 |
경희대학교 산학협력단 |
이질균에 특이적 사멸능을 갖는 박테리오파지
|
|
TW201130980A
(en)
*
|
2010-03-02 |
2011-09-16 |
Univ Ishou |
A new lytic phage specific to Klebsiella pneumoniae
|
|
CA3154006C
(en)
|
2010-09-17 |
2025-09-09 |
Technophage, Investigacao E Desenvolvimento Em Biotecnologia S.A. |
Antibacterial phages, phage peptides and their methods of use
|
|
US8597928B2
(en)
|
2010-12-21 |
2013-12-03 |
Cj Cheiljedang Corporation |
Bacteriophage of the siphoviridae family and antibacterial compositions comprising the same
|
|
KR101432872B1
(ko)
|
2011-09-20 |
2014-08-27 |
씨제이제일제당 (주) |
신규 박테리오파지 및 이를 포함하는 항균 조성물
|
|
KR101279780B1
(ko)
|
2011-10-05 |
2013-06-28 |
주식회사 인트론바이오테크놀로지 |
액티노바실러스 플루로뉴모니애에 대한 사멸능을 갖는 박테리오파지
|
|
KR101260645B1
(ko)
|
2011-11-14 |
2013-05-03 |
씨제이제일제당 (주) |
대장균 특이적 사멸능을 나타내는 신규 분리된 박테리오파지 및 이를 포함하는 항균 조성물
|
|
BR112014023005A2
(pt)
|
2012-03-17 |
2017-07-18 |
Univ California |
diagnóstico rápido e tratamentos personalizados para acne
|
|
KR101299179B1
(ko)
*
|
2012-04-18 |
2013-08-22 |
씨제이제일제당 (주) |
신규 박테리오파지 및 이를 포함하는 항균 조성물
|
|
EP3685851A1
(en)
*
|
2012-05-09 |
2020-07-29 |
Contrafect Corporation |
Bacteriophage lysin and antibiotic combinations against gram positive bacteria
|
|
EP2970917A2
(en)
|
2013-03-15 |
2016-01-20 |
Altria Client Services LLC |
Bacteriophage and methods of making and using
|
|
KR101591783B1
(ko)
|
2014-04-15 |
2016-02-04 |
씨제이제일제당(주) |
신규 박테리오파지 및 이를 포함하는 조성물
|
|
RU2565559C1
(ru)
*
|
2014-11-19 |
2015-10-20 |
Федеральное государственное бюджетное учреждение науки Институт химической биологии и фундаментальной медицины Сибирского отделения Российской академии наук (ИХБФМ СО РАН) |
ШТАММ БАКТЕРИОФАГА Citrobacter freundii CF17, СПОСОБНЫЙ ЛИЗИРОВАТЬ ПАТОГЕННЫЕ ШТАММЫ CITROBACTER FREUNDII
|
|
US10357056B2
(en)
|
2015-01-29 |
2019-07-23 |
Altria Client Services Llc |
Endolysin from bacteriophage against Geobacillus and methods of using
|
|
WO2016123427A1
(en)
|
2015-01-29 |
2016-08-04 |
Altria Client Services Llc |
Bacteriophage and methods of using
|
|
WO2016168560A1
(en)
|
2015-04-16 |
2016-10-20 |
Kennesaw State University Research And Service Foundation, Inc. |
Escherichia coli o157:h7 bacteriophage φ241
|
|
KR102011956B1
(ko)
*
|
2017-06-19 |
2019-08-19 |
주식회사 마이크로바이오틱스 |
항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지
|
|
KR102011965B1
(ko)
*
|
2017-06-19 |
2019-08-19 |
주식회사 마이크로바이오틱스 |
항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지
|
|
KR101940019B1
(ko)
*
|
2017-06-19 |
2019-01-18 |
연세대학교 산학협력단 |
항생제 내성을 갖는 클렙시엘라(Klebsiella)속 균을 용균하는 박테리오파지
|
|
WO2020257502A1
(en)
*
|
2019-06-21 |
2020-12-24 |
Laboratory Corporation Of America Holdings |
Methods for producing mutant bacteriophages for the detection of listeria
|
|
BR112022017797A2
(pt)
*
|
2020-03-06 |
2022-11-29 |
Endolytix Tech Inc |
Métodos de distribuição de um bacteriófago, de tratamento de uma infecção bacteriana, de isolamento de um fago direcionado a uma bactéria e composição
|
|
BR112022017792A2
(pt)
*
|
2020-03-06 |
2022-11-29 |
Endolytix Tech Inc |
Métodos de distribuição de um bacteriófago, de tratamento de uma infecção bacteriana intracelular e de isolamento de um fago direcionado a uma bactéria e composições
|
|
KR102586836B1
(ko)
|
2021-02-23 |
2023-10-10 |
씨제이제일제당 주식회사 |
클로스트리디움 퍼프린젠스에 대한 특이적인 사멸능을 가지는 신규한 박테리오파지 및 이를 포함하는 항균 조성물
|
|
KR102586835B1
(ko)
|
2021-02-23 |
2023-10-10 |
씨제이제일제당 주식회사 |
장독소성 대장균에 대한 특이적인 사멸능을 가지는 신규한 박테리오파지 및 이를 포함하는 항균 조성물
|
|
KR102586837B1
(ko)
|
2021-02-23 |
2023-10-10 |
씨제이제일제당 주식회사 |
클로스트리디움 퍼프린젠스에 대한 특이적인 사멸능을 가지는 신규한 박테리오파지 및 이를 포함하는 항균 조성물
|
|
KR102586839B1
(ko)
|
2021-02-25 |
2023-10-10 |
씨제이제일제당 주식회사 |
클로스트리디움 퍼프린젠스에 대한 특이적인 사멸능을 가지는 신규한 박테리오파지 및 이를 포함하는 항균 조성물
|
|
KR102586838B1
(ko)
*
|
2021-02-25 |
2023-10-10 |
씨제이제일제당 주식회사 |
클로스트리디움 퍼프린젠스에 대한 특이적인 사멸능을 가지는 신규한 박테리오파지 및 이를 포함하는 항균 조성물
|
|
CN119799652A
(zh)
*
|
2024-11-29 |
2025-04-11 |
瑞科盟(青岛)生物工程有限公司 |
一株产酸克雷伯菌噬菌体rdp-ec-23031及其应用
|